カテゴリー： Market Monitor Global, 世界, 医療/バイオ

フィンゴリモドの世界市場見通し2023年-2029年

◆英語タイトル：Fingolimod Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5563）

◆商品コード：MMG23JU5563
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Fingolimod Market 調査レポートは次の情報を含め、グローバルにおけるのフィンゴリモド市場規模と予測を収録しています。・世界のフィンゴリモド市場：売上、2018年-2023年、2024年-2029年
・世界のフィンゴリモド市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のフィンゴリモド市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

フィンゴリモドのグローバル主要企業は、Novartis、 AstraZenecaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、フィンゴリモドのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のフィンゴリモド市場：タイプ別、2018年-2023年、2024年-2029年
世界のフィンゴリモド市場：タイプ別市場シェア、2022年
・経口、注射

世界のフィンゴリモド市場：用途別、2018年-2023年、2024年-2029年
世界のフィンゴリモド市場：用途別市場シェア、2022年
・医療用、科学研究用、その他

世界のフィンゴリモド市場：地域・国別、2018年-2023年、2024年-2029年
世界のフィンゴリモド市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるフィンゴリモドのグローバル売上、2018年-2023年
・主要企業におけるフィンゴリモドのグローバル売上シェア、2022年
・主要企業におけるフィンゴリモドのグローバル販売量、2018年-2023年
・主要企業におけるフィンゴリモドのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis、 AstraZeneca

*************************************************************

・調査・分析レポートの概要
フィンゴリモド市場の定義
市場セグメント
世界のフィンゴリモド市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のフィンゴリモド市場規模
世界のフィンゴリモド市場規模：2022年 VS 2029年
世界のフィンゴリモド市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのフィンゴリモドの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のフィンゴリモド製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：経口、注射
フィンゴリモドのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：医療用、科学研究用、その他
フィンゴリモドの用途別グローバル売上・予測

・地域別市場分析
地域別フィンゴリモド市場規模 2022年と2029年
地域別フィンゴリモド売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis、 AstraZeneca
...

This report aims to provide a comprehensive presentation of the global market for Fingolimod, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fingolimod. This report contains market size and forecasts of Fingolimod in global, including the following market information:
Global Fingolimod Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Fingolimod Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Fingolimod companies in 2022 (%)
The global Fingolimod market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fingolimod include Novartis and AstraZeneca etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fingolimod manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fingolimod Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Fingolimod Market Segment Percentages, by Type, 2022 (%)
Oral
Injection
Global Fingolimod Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Fingolimod Market Segment Percentages, by Application, 2022 (%)
Medical Field
Science Research Field
Other Fields
Global Fingolimod Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Fingolimod Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fingolimod revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Fingolimod revenues share in global market, 2022 (%)
Key companies Fingolimod sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Fingolimod sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fingolimod, market overview.
Chapter 2: Global Fingolimod market size in revenue and volume.
Chapter 3: Detailed analysis of Fingolimod manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fingolimod in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fingolimod capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Fingolimod Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fingolimod Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fingolimod Overall Market Size
2.1 Global Fingolimod Market Size: 2022 VS 2029
2.2 Global Fingolimod Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Fingolimod Sales: 2018-2029
3 Company Landscape
3.1 Top Fingolimod Players in Global Market
3.2 Top Global Fingolimod Companies Ranked by Revenue
3.3 Global Fingolimod Revenue by Companies
3.4 Global Fingolimod Sales by Companies
3.5 Global Fingolimod Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Fingolimod Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Fingolimod Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fingolimod Players in Global Market
3.8.1 List of Global Tier 1 Fingolimod Companies
3.8.2 List of Global Tier 2 and Tier 3 Fingolimod Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Fingolimod Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Injection
4.2 By Type – Global Fingolimod Revenue & Forecasts
4.2.1 By Type – Global Fingolimod Revenue, 2018-2023
4.2.2 By Type – Global Fingolimod Revenue, 2024-2029
4.2.3 By Type – Global Fingolimod Revenue Market Share, 2018-2029
4.3 By Type – Global Fingolimod Sales & Forecasts
4.3.1 By Type – Global Fingolimod Sales, 2018-2023
4.3.2 By Type – Global Fingolimod Sales, 2024-2029
4.3.3 By Type – Global Fingolimod Sales Market Share, 2018-2029
4.4 By Type – Global Fingolimod Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Fingolimod Market Size, 2022 & 2029
5.1.2 Medical Field
5.1.3 Science Research Field
5.1.4 Other Fields
5.2 By Application – Global Fingolimod Revenue & Forecasts
5.2.1 By Application – Global Fingolimod Revenue, 2018-2023
5.2.2 By Application – Global Fingolimod Revenue, 2024-2029
5.2.3 By Application – Global Fingolimod Revenue Market Share, 2018-2029
5.3 By Application – Global Fingolimod Sales & Forecasts
5.3.1 By Application – Global Fingolimod Sales, 2018-2023
5.3.2 By Application – Global Fingolimod Sales, 2024-2029
5.3.3 By Application – Global Fingolimod Sales Market Share, 2018-2029
5.4 By Application – Global Fingolimod Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Fingolimod Market Size, 2022 & 2029
6.2 By Region – Global Fingolimod Revenue & Forecasts
6.2.1 By Region – Global Fingolimod Revenue, 2018-2023
6.2.2 By Region – Global Fingolimod Revenue, 2024-2029
6.2.3 By Region – Global Fingolimod Revenue Market Share, 2018-2029
6.3 By Region – Global Fingolimod Sales & Forecasts
6.3.1 By Region – Global Fingolimod Sales, 2018-2023
6.3.2 By Region – Global Fingolimod Sales, 2024-2029
6.3.3 By Region – Global Fingolimod Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Fingolimod Revenue, 2018-2029
6.4.2 By Country – North America Fingolimod Sales, 2018-2029
6.4.3 US Fingolimod Market Size, 2018-2029
6.4.4 Canada Fingolimod Market Size, 2018-2029
6.4.5 Mexico Fingolimod Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Fingolimod Revenue, 2018-2029
6.5.2 By Country – Europe Fingolimod Sales, 2018-2029
6.5.3 Germany Fingolimod Market Size, 2018-2029
6.5.4 France Fingolimod Market Size, 2018-2029
6.5.5 U.K. Fingolimod Market Size, 2018-2029
6.5.6 Italy Fingolimod Market Size, 2018-2029
6.5.7 Russia Fingolimod Market Size, 2018-2029
6.5.8 Nordic Countries Fingolimod Market Size, 2018-2029
6.5.9 Benelux Fingolimod Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Fingolimod Revenue, 2018-2029
6.6.2 By Region – Asia Fingolimod Sales, 2018-2029
6.6.3 China Fingolimod Market Size, 2018-2029
6.6.4 Japan Fingolimod Market Size, 2018-2029
6.6.5 South Korea Fingolimod Market Size, 2018-2029
6.6.6 Southeast Asia Fingolimod Market Size, 2018-2029
6.6.7 India Fingolimod Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Fingolimod Revenue, 2018-2029
6.7.2 By Country – South America Fingolimod Sales, 2018-2029
6.7.3 Brazil Fingolimod Market Size, 2018-2029
6.7.4 Argentina Fingolimod Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Fingolimod Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Fingolimod Sales, 2018-2029
6.8.3 Turkey Fingolimod Market Size, 2018-2029
6.8.4 Israel Fingolimod Market Size, 2018-2029
6.8.5 Saudi Arabia Fingolimod Market Size, 2018-2029
6.8.6 UAE Fingolimod Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Fingolimod Major Product Offerings
7.1.4 Novartis Fingolimod Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Fingolimod Major Product Offerings
7.2.4 AstraZeneca Fingolimod Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
8 Global Fingolimod Production Capacity, Analysis
8.1 Global Fingolimod Production Capacity, 2018-2029
8.2 Fingolimod Production Capacity of Key Manufacturers in Global Market
8.3 Global Fingolimod Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fingolimod Supply Chain Analysis
10.1 Fingolimod Industry Value Chain
10.2 Fingolimod Upstream Market
10.3 Fingolimod Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fingolimod Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Fingolimod in Global Market
Table 2. Top Fingolimod Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Fingolimod Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Fingolimod Revenue Share by Companies, 2018-2023
Table 5. Global Fingolimod Sales by Companies, (K MT), 2018-2023
Table 6. Global Fingolimod Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Fingolimod Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Fingolimod Product Type
Table 9. List of Global Tier 1 Fingolimod Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fingolimod Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Fingolimod Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Fingolimod Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Fingolimod Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Fingolimod Sales (K MT), 2018-2023
Table 15. By Type - Global Fingolimod Sales (K MT), 2024-2029
Table 16. By Application – Global Fingolimod Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Fingolimod Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Fingolimod Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Fingolimod Sales (K MT), 2018-2023
Table 20. By Application - Global Fingolimod Sales (K MT), 2024-2029
Table 21. By Region – Global Fingolimod Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Fingolimod Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Fingolimod Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Fingolimod Sales (K MT), 2018-2023
Table 25. By Region - Global Fingolimod Sales (K MT), 2024-2029
Table 26. By Country - North America Fingolimod Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Fingolimod Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Fingolimod Sales, (K MT), 2018-2023
Table 29. By Country - North America Fingolimod Sales, (K MT), 2024-2029
Table 30. By Country - Europe Fingolimod Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Fingolimod Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Fingolimod Sales, (K MT), 2018-2023
Table 33. By Country - Europe Fingolimod Sales, (K MT), 2024-2029
Table 34. By Region - Asia Fingolimod Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Fingolimod Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Fingolimod Sales, (K MT), 2018-2023
Table 37. By Region - Asia Fingolimod Sales, (K MT), 2024-2029
Table 38. By Country - South America Fingolimod Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Fingolimod Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Fingolimod Sales, (K MT), 2018-2023
Table 41. By Country - South America Fingolimod Sales, (K MT), 2024-2029
Table 42. By Country - Middle East & Africa Fingolimod Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Fingolimod Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Fingolimod Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Fingolimod Sales, (K MT), 2024-2029
Table 46. Novartis Company Summary
Table 47. Novartis Fingolimod Product Offerings
Table 48. Novartis Fingolimod Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Fingolimod Product Offerings
Table 52. AstraZeneca Fingolimod Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Fingolimod Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 55. Global Fingolimod Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Fingolimod Production by Region, 2018-2023 (K MT)
Table 57. Global Fingolimod Production by Region, 2024-2029 (K MT)
Table 58. Fingolimod Market Opportunities & Trends in Global Market
Table 59. Fingolimod Market Drivers in Global Market
Table 60. Fingolimod Market Restraints in Global Market
Table 61. Fingolimod Raw Materials
Table 62. Fingolimod Raw Materials Suppliers in Global Market
Table 63. Typical Fingolimod Downstream
Table 64. Fingolimod Downstream Clients in Global Market
Table 65. Fingolimod Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Fingolimod Segment by Type in 2022
Figure 2. Fingolimod Segment by Application in 2022
Figure 3. Global Fingolimod Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Fingolimod Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Fingolimod Revenue, 2018-2029 (US$, Mn)
Figure 7. Fingolimod Sales in Global Market: 2018-2029 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Fingolimod Revenue in 2022
Figure 9. By Type - Global Fingolimod Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Fingolimod Revenue Market Share, 2018-2029
Figure 11. By Type - Global Fingolimod Sales Market Share, 2018-2029
Figure 12. By Type - Global Fingolimod Price (USD/MT), 2018-2029
Figure 13. By Application - Global Fingolimod Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Fingolimod Revenue Market Share, 2018-2029
Figure 15. By Application - Global Fingolimod Sales Market Share, 2018-2029
Figure 16. By Application - Global Fingolimod Price (USD/MT), 2018-2029
Figure 17. By Region - Global Fingolimod Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Fingolimod Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Fingolimod Revenue Market Share, 2018-2029
Figure 20. By Region - Global Fingolimod Sales Market Share, 2018-2029
Figure 21. By Country - North America Fingolimod Revenue Market Share, 2018-2029
Figure 22. By Country - North America Fingolimod Sales Market Share, 2018-2029
Figure 23. US Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Fingolimod Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Fingolimod Sales Market Share, 2018-2029
Figure 28. Germany Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 29. France Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Fingolimod Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Fingolimod Sales Market Share, 2018-2029
Figure 37. China Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 41. India Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Fingolimod Revenue Market Share, 2018-2029
Figure 43. By Country - South America Fingolimod Sales Market Share, 2018-2029
Figure 44. Brazil Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Fingolimod Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Fingolimod Sales Market Share, 2018-2029
Figure 48. Turkey Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Fingolimod Revenue, (US$, Mn), 2018-2029
Figure 52. Global Fingolimod Production Capacity (K MT), 2018-2029
Figure 53. The Percentage of Production Fingolimod by Region, 2022 VS 2029
Figure 54. Fingolimod Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ フィンゴリモドの世界市場見通し2023年-2029年(Fingolimod Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

フィンゴリモドの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp